Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
03/28/2023
Jolynn Tumolo
Researchers studied a JAK inhibitor's efficacy for improving disease activity, health-related quality of life, and other measures in a cohort of patients with ankylosing spondylitis who did not respond or tolerate biologics.
Researchers studied a JAK inhibitor's efficacy for improving disease activity, health-related quality of life, and other measures in a cohort of patients with ankylosing spondylitis who did not respond or tolerate biologics.
Researchers studied a JAK...
03/28/2023
First Report Managed Care
News
03/28/2023
Jolynn Tumolo
While traditional Medicare operating margins declined, financial shortfalls for fee-for-service Medicare members increased, according to findings from a recent analysis.
While traditional Medicare operating margins declined, financial shortfalls for fee-for-service Medicare members increased, according to findings from a recent analysis.
While traditional Medicare...
03/28/2023
First Report Managed Care
News
03/27/2023
Jolynn Tumolo
Sugasini Dhavamani, PhD, a assistant professor at the University of Illinois at Chicago, presented findings at the annual meeting of the American Society for Biochemistry and Molecular Biology.
Sugasini Dhavamani, PhD, a assistant professor at the University of Illinois at Chicago, presented findings at the annual meeting of the American Society for Biochemistry and Molecular Biology.
Sugasini Dhavamani, PhD, a...
03/27/2023
Psych Congress Network
News
03/27/2023
Jolynn Tumolo
Existing research supports the use of wearable devices to monitor gait freezing and falls in patients with Parkinson disease, but further efforts are needed to address study limitations such as low participant number and setting, authors...
Existing research supports the use of wearable devices to monitor gait freezing and falls in patients with Parkinson disease, but further efforts are needed to address study limitations such as low participant number and setting, authors...
Existing research supports the...
03/27/2023
Annals of Long-Term Care
News
03/27/2023
Jolynn Tumolo
Clinical trials of Bruton tyrosine kinase inhibitors in patients with multiple sclerosis are yielding encouraging results, but more research is needed to determine their long-term effects and place within the therapeutic landscape.
Clinical trials of Bruton tyrosine kinase inhibitors in patients with multiple sclerosis are yielding encouraging results, but more research is needed to determine their long-term effects and place within the therapeutic landscape.
Clinical trials of Bruton...
03/27/2023
Veterans Health Today
News
03/27/2023
Jolynn Tumolo
“In cases with a diagnosis of CLL, care should be taken to detect other malignancies,” researchers wrote, “and it should be kept in mind that the presence of other malignancies may reduce survival.”
“In cases with a diagnosis of CLL, care should be taken to detect other malignancies,” researchers wrote, “and it should be kept in mind that the presence of other malignancies may reduce survival.”
“In cases with a diagnosis of...
03/27/2023
First Report Managed Care
News
03/24/2023
Jolynn Tumolo
A class II recall has been issued for more than 700,000 lots of OTC eye solution for failing to meet impurities specifications.
A class II recall has been issued for more than 700,000 lots of OTC eye solution for failing to meet impurities specifications.
A class II recall has been...
03/24/2023
Pharmacy Learning Network
News
03/24/2023
Jolynn Tumolo
A recall has been issued for colchicine tablets after testing revealed one lot was out of specification for the related substance beta-Lumicolchicine.
A recall has been issued for colchicine tablets after testing revealed one lot was out of specification for the related substance beta-Lumicolchicine.
A recall has been issued for...
03/24/2023
Pharmacy Learning Network
News
03/24/2023
Jolynn Tumolo
A recall has been issued for buprenorphine transdermal systems for failing to meet impurity/degradation specifications.
A recall has been issued for buprenorphine transdermal systems for failing to meet impurity/degradation specifications.
A recall has been issued for...
03/24/2023
Pharmacy Learning Network
News
03/23/2023
Jolynn Tumolo
A 58-year-old woman developed retroperitoneal fibrosis 5 weeks after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, findings show.
A 58-year-old woman developed retroperitoneal fibrosis 5 weeks after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, findings show.
A 58-year-old woman developed...
03/23/2023
First Report Managed Care